Techno Medical PCLBKK:TM-R 77 Debt-to-EBITDA is 3.87 as of Mar. 2026, which is 8% above its 10-year median of 3.58. GuruFocus rates BKK:TM-R with a GF Score™ of 77/100 and a GF Value™ of ฿2.99. The stock has 6 warning signs investors should review. Among 90 Medical Distribution companies, Techno Medical PCL ranks worse than 67.78% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Techno Medical PCL's Debt-to-EBITDA or its related term are showing as below:
BKK:TM-R'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.23 Med: 3.58 Max: 11.02
Current: 3.94
During the past 11 years, the highest Debt-to-EBITDA Ratio of Techno Medical PCL was 11.02. The lowest was 2.23. And the median was 3.58.
BKK:TM-R's Debt-to-EBITDA is ranked worse than 67.78% of 90
companies
in the Medical Distribution industry
Industry Median: 2.45
vs BKK:TM-R: 3.94
Techno Medical PCL (BKK:TM-R) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Techno Medical PCL Debt-to-EBITDA Related Terms
Techno Medical PCL Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TM-R vs MCK, CAH, COR: Debt-to-EBITDA Comparison
For the Medical Distribution subindustry, Techno Medical PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Techno Medical PCL (BKK:TM-R) has a Debt-to-EBITDA of 3.87 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Techno Medical PCL. This is near median its historical median of 3.58. Over the past decade, Techno Medical PCL's Debt-to-EBITDA has ranged from 2.23 to 11.02. According to the industry distribution chart, Techno Medical PCL ranks #61 out of 90 companies in the Medical Distribution industry, placing it in the top 67.8%.
Is Techno Medical PCL's Debt-to-EBITDA too high?
Techno Medical PCL's current Debt-to-EBITDA of 3.87 is near median its 10-year median of 3.58. Over the past 10 years, this metric has ranged from a low of 2.23 to a high of 11.02. The Medical Distribution industry median Debt-to-EBITDA is 2.45. Techno Medical PCL's value of 3.87 is 58% above this industry median. Based on the distribution chart, Techno Medical PCL ranks #61 out of 90 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Techno Medical PCL has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's Debt-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #61 out of 90 companies for Debt-to-EBITDA. This places Techno Medical PCL in the lower half of its industry. The industry median Debt-to-EBITDA is 2.45. Techno Medical PCL's value of 3.87 is 58% above this benchmark. Historically, Techno Medical PCL's own Debt-to-EBITDA has ranged from 2.23 to 11.02 over the past decade. While the company's 10-year median is 3.58 vs. the industry median of 2.45, Techno Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.45, based on 90 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current Debt-to-EBITDA of 3.87 is 58% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Techno Medical PCL. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current Debt-to-EBITDA is 3.87, which is near median its own 10-year median of 3.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current Debt-to-EBITDA of 3.87. The stock's GF Value™ is ฿2.99, compared to a current price of ฿2.32 — trading 22.4% below its estimated fair value. The current Debt-to-EBITDA is 3.87, which is near median its 10-year median of 3.58 and 58% above the Medical Distribution industry median of 2.45. Techno Medical PCL's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current Debt-to-EBITDA is 3.87 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 22.4% below its estimated GF Value™ of ฿2.99.
Key valuation signals for BKK:TM-R:
Debt-to-EBITDA: 3.87 (near median its 10-year median of 3.58)
GF Value™: ฿2.99 vs. price of ฿2.32 (22.4% below fair value)
Industry Position: 58% above the Medical Distribution median (#61 of 90)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
77GF Score
Get the complete analysis for BKK:TM-R
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 
